Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01288807 · ClinicalTrials.gov registry record · Phase 4
Effect of Milnacipran on Pain in Fibromyalgia
A Phase 4 study of Fibromyalgia, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT01288807: Completed Phase 4 study of Fibromyalgia, sponsored by University of California, San Diego.
NCT01288807 is a Phase 4 study of Fibromyalgia that has completed, run by University of California, San Diego. The registered enrollment target is 8 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01288807, a Phase 4 study of Fibromyalgia, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators want to study the effects of milnacipran treatment on neurotransmitter release in fibromyalgia.
Primary Outcome
Measure levels of Substance P present in serial samples of CSF and plasma collected over the course of 4 hours in response to application of a painful thermal stimulus at baseline ("before") and the end of 12 weeks of treatment with milnacipran 200mg daily ("after"). Substance P levels are presented. Presented data show the 10 minute and 40 minute timepoint for Substance P after pain challenge. Additional time points were not analyzed.
Conditions Studied
Interventions
- DRUG Milnacipram
Study Locations (1)
California
- UCSD Medical Center, La Jolla - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
What the finished NCT01288807 record still lists
NCT01288807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Milnacipram is the first listed.
NCT01288807 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01288807 about?
NCT01288807 is a clinical study titled "Effect of Milnacipran on Pain in Fibromyalgia". The investigators want to study the effects of milnacipran treatment on neurotransmitter release in fibromyalgia.
What is the current status of trial NCT01288807?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2011-02. Estimated completion is 2015-01.
What conditions does trial NCT01288807 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT01288807?
The interventions under investigation include: Milnacipram (DRUG).
Who is sponsoring clinical trial NCT01288807?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01288807 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01288807's enrollment target sits among peer trials
8 75th of 76 higher than 2 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
COMPLETED · Phase 4
-
A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia
COMPLETED · Phase 4
-
Quetiapine Compared With Placebo in the Management of Fibromyalgia
COMPLETED · Phase 4
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Nitrous Oxide as Treatment for Fibromyalgia
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia